GSK to cut 1,200+ jobs in Belgium, BioSpace tracker reports

BioSpace reported on 15 October 2026 that GSK plans to lay off more than 1,200 people in Belgium. The update came via the outlet's Layoff Tracker, with the headline stating "GSK plans to lay off 1.2K+ in Belgium". No further details on sites, roles, or timing were included in the material provided.

At a glance

Why it matters

For jobseekers, a headline number like this is a signal, not a full picture. Belgium is one of GSK's largest manufacturing and R&D hubs in Europe, so a cut of this scale will be watched closely by suppliers, contractors, and people hoping to move into pharma roles there.

General context - clearly labelled: When large pharma firms announce cuts in Belgium, the process is typically governed by Belgian collective dismissal rules. That usually means information and consultation with works councils and unions before any individual notices go out. Timelines can stretch over months. Roles are often phased rather than removed in one day. None of that detail has been confirmed for this specific GSK plan in the material we have - it is general background to help you interpret what a "plans to lay off" headline usually means in practice.

It also matters because BioSpace tracks these moves across the industry. A single entry in a layoff tracker often precedes more detailed company statements, regulatory filings, or local press reports that will name the sites and functions affected.

Key details

Here is what is actually confirmed from the material provided:

• Who: GSK
• What: Plan to lay off 1,200+ employees
• Where: Belgium
• When reported: Thu, 15 Oct 2026 07:00:00 GMT by BioSpace

What has not been announced in the material:

• Which GSK sites in Belgium are affected
• Which departments or job families - manufacturing, R&D, commercial, support functions
• Start date, end date, or whether this is voluntary, involuntary, or through non-renewal of contracts
• Severance terms or redeployment options

We are not adding those specifics because they were not in the source material. If you see other outlets quoting site names or exact dates, check whether they link to a GSK press release or a Belgian regulatory filing.

What to do next

If you work at GSK in Belgium or are applying there, don't act on the headline alone.

• Track the primary source: Watch for a formal GSK statement and any filing with Belgian authorities. The BioSpace tracker entry should be treated as an alert, not the final notice.
• If you are an internal employee: Wait for works council and HR communications. Keep copies of your contract, recent performance reviews, and any training certificates. Note internal mobility deadlines.
• If you are a jobseeker outside GSK: Hiring freezes often accompany restructuring. Check GSK's own careers portal for live requisitions in Belgium before you apply, and be prepared for slower feedback.
• For applicants from Nepal: This is not a foreign employment recruitment. Belgium-bound work generally goes through employer-sponsored permits, not the Department of Foreign Employment mass recruitment route. If you are approached by an agent offering "GSK Belgium" jobs for a fee, verify the employer directly and apply only through official channels. Typical documents for legitimate skilled moves include passport, education equivalence, experience letters, and language proof if required - but no fee should be paid to secure a GSK role.

We will update this piece when GSK publishes site-level detail or a timeline.

Bottom line: the only hard fact right now is the scale and location - 1,200+ roles in Belgium flagged by BioSpace on 15 October. Everything else is still to be confirmed.